Taiwan · Delayed Price · Currency is TWD Bonraybio Statistics
Total Valuation
Bonraybio has a market cap or net worth of TWD 4.02 billion. The enterprise value is 3.50 billion.
| Market Cap | 4.02B |
| Enterprise Value | 3.50B |
Important Dates
The next estimated earnings date is Thursday, February 26, 2026.
| Earnings Date | Feb 26, 2026 |
| Ex-Dividend Date | Mar 27, 2025 |
Share Statistics
Bonraybio has 24.80 million shares outstanding. The number of shares has increased by 8.11% in one year.
| Current Share Class | 24.80M |
| Shares Outstanding | 24.80M |
| Shares Change (YoY) | +8.11% |
| Shares Change (QoQ) | -0.00% |
| Owned by Insiders (%) | 10.17% |
| Owned by Institutions (%) | 4.56% |
| Float | 10.55M |
Valuation Ratios
The trailing PE ratio is 41.31.
| PE Ratio | 41.31 |
| Forward PE | n/a |
| PS Ratio | 13.99 |
| PB Ratio | 6.57 |
| P/TBV Ratio | 6.82 |
| P/FCF Ratio | 51.54 |
| P/OCF Ratio | 43.68 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 33.14, with an EV/FCF ratio of 44.89.
| EV / Earnings | 36.34 |
| EV / Sales | 12.19 |
| EV / EBITDA | 33.14 |
| EV / EBIT | 37.28 |
| EV / FCF | 44.89 |
Financial Position
The company has a current ratio of 13.02, with a Debt / Equity ratio of 0.01.
| Current Ratio | 13.02 |
| Quick Ratio | 11.93 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.07 |
| Debt / FCF | 0.10 |
| Interest Coverage | 536.35 |
Financial Efficiency
Return on equity (ROE) is 20.67% and return on invested capital (ROIC) is 12.35%.
| Return on Equity (ROE) | 20.67% |
| Return on Assets (ROA) | 11.46% |
| Return on Invested Capital (ROIC) | 12.35% |
| Return on Capital Employed (ROCE) | 15.24% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.56 |
| Inventory Turnover | 1.97 |
Taxes
In the past 12 months, Bonraybio has paid 1.76 million in taxes.
| Income Tax | 1.76M |
| Effective Tax Rate | 1.80% |
Stock Price Statistics
The stock price has increased by +27.38% in the last 52 weeks. The beta is -0.19, so Bonraybio's price volatility has been lower than the market average.
| Beta (5Y) | -0.19 |
| 52-Week Price Change | +27.38% |
| 50-Day Moving Average | 158.90 |
| 200-Day Moving Average | 153.73 |
| Relative Strength Index (RSI) | 57.52 |
| Average Volume (20 Days) | 7,819 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Bonraybio had revenue of TWD 287.10 million and earned 96.28 million in profits. Earnings per share was 3.92.
| Revenue | 287.10M |
| Gross Profit | 224.28M |
| Operating Income | 93.86M |
| Pretax Income | 98.04M |
| Net Income | 96.28M |
| EBITDA | 102.32M |
| EBIT | 93.86M |
| Earnings Per Share (EPS) | 3.92 |
Balance Sheet
The company has 526.69 million in cash and 7.77 million in debt, with a net cash position of 518.92 million or 20.92 per share.
| Cash & Cash Equivalents | 526.69M |
| Total Debt | 7.77M |
| Net Cash | 518.92M |
| Net Cash Per Share | 20.92 |
| Equity (Book Value) | 611.35M |
| Book Value Per Share | 24.65 |
| Working Capital | 551.47M |
Cash Flow
In the last 12 months, operating cash flow was 91.99 million and capital expenditures -14.04 million, giving a free cash flow of 77.95 million.
| Operating Cash Flow | 91.99M |
| Capital Expenditures | -14.04M |
| Free Cash Flow | 77.95M |
| FCF Per Share | 3.14 |
Margins
Gross margin is 78.12%, with operating and profit margins of 32.69% and 33.54%.
| Gross Margin | 78.12% |
| Operating Margin | 32.69% |
| Pretax Margin | 34.15% |
| Profit Margin | 33.54% |
| EBITDA Margin | 35.64% |
| EBIT Margin | 32.69% |
| FCF Margin | 27.15% |
Dividends & Yields
This stock pays an annual dividend of 1.30, which amounts to a dividend yield of 0.82%.
| Dividend Per Share | 1.30 |
| Dividend Yield | 0.82% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 2 |
| Payout Ratio | 33.60% |
| Buyback Yield | -8.11% |
| Shareholder Yield | -7.29% |
| Earnings Yield | 2.40% |
| FCF Yield | 1.94% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on August 25, 2025. It was a forward split with a ratio of 1.15.
| Last Split Date | Aug 25, 2025 |
| Split Type | Forward |
| Split Ratio | 1.15 |
Scores
Bonraybio has an Altman Z-Score of 42.4 and a Piotroski F-Score of 5.
| Altman Z-Score | 42.4 |
| Piotroski F-Score | 5 |